Enveric Biosciences Statistics Share Statistics Enveric Biosciences has 2.47M
shares outstanding. The number of shares has increased by -72.43%
in one year.
Shares Outstanding 2.47M Shares Change (YoY) -72.43% Shares Change (QoQ) 28.6% Owned by Institutions (%) 12.4% Shares Floating 2.14M Failed to Deliver (FTD) Shares 338 FTD / Avg. Volume 0.13%
Short Selling Information The latest short interest is 213.5K, so 8.64% of the outstanding
shares have been sold short.
Short Interest 213.5K Short % of Shares Out 8.64% Short % of Float 8.72% Short Ratio (days to cover) 1.42
Valuation Ratios The PE ratio is -0.28 and the forward
PE ratio is -0.04.
Enveric Biosciences's PEG ratio is
0.
PE Ratio -0.28 Forward PE -0.04 PS Ratio 0 Forward PS 0.3 PB Ratio 1.7 P/FCF Ratio -0.35 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Enveric Biosciences.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.84,
with a Debt / Equity ratio of 0.
Current Ratio 1.84 Quick Ratio 1.84 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.91M Employee Count 5 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 8.93K Effective Tax Rate -0.09%
Stock Price Statistics The stock price has increased by -86.4% in the
last 52 weeks. The beta is 0.37, so Enveric Biosciences's
price volatility has been higher than the market average.
Beta 0.37 52-Week Price Change -86.4% 50-Day Moving Average 1.26 200-Day Moving Average 2.92 Relative Strength Index (RSI) 35.44 Average Volume (20 Days) 261,246
Income Statement
Revenue n/a Gross Profit n/a Operating Income -9.63M Net Income -9.57M EBITDA -9.23M EBIT -9.57M Earnings Per Share (EPS) -19.04
Full Income Statement Balance Sheet The company has 2.24M in cash and 0 in
debt, giving a net cash position of 2.24M.
Cash & Cash Equivalents 2.24M Total Debt n/a Net Cash n/a Retained Earnings -106.07M Total Assets 5.1M Working Capital 3.65M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -7.73M
and capital expenditures 0, giving a free cash flow of -7.73M.
Operating Cash Flow -7.73M Capital Expenditures n/a Free Cash Flow -7.73M FCF Per Share -15.36
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields ENVB does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for ENVB is $10,
which is 834.6% higher than the current price. The consensus rating is "Buy".
Price Target $10 Price Target Difference 834.6% Analyst Consensus Buy Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jul 15, 2022. It was a
backward
split with a ratio of 1:50.
Last Split Date Jul 15, 2022 Split Type backward Split Ratio 1:50
Scores Altman Z-Score -33.5 Piotroski F-Score 3
